Extension to Study on Efficacy and Safety of Linzagolix for the Treatment of Endometriosis-associated Pain (EDELWEISS 6)
Clinical trial NCT04335591 · COMPLETED
Trial details
- NCT number
- NCT04335591
- Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-05
- Primary completion
- 2022-09-15
- Enrollment
- 356
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.